Pages that link to "Q46724711"
Jump to navigation
Jump to search
The following pages link to First in vivo evidence of an NMDA receptor deficit in medication-free schizophrenic patients (Q46724711):
Displaying 50 items.
- Positive allosteric modulation of metabotropic glutamate 5 (mGlu5) receptors reverses N-Methyl-D-aspartate antagonist-induced alteration of neuronal firing in prefrontal cortex (Q24602550) (← links)
- MicroRNA dysregulation in psychiatric disease (Q24630375) (← links)
- Mutant mouse models: genotype-phenotype relationships to negative symptoms in schizophrenia (Q24632939) (← links)
- Autoantibodies to central nervous system neuronal surface antigens: psychiatric symptoms and psychopharmacological implications (Q26775915) (← links)
- GABAergic interneurons shape the functional maturation of the cortex (Q26825288) (← links)
- Positive allosteric modulators of metabotropic glutamate 2 receptors in schizophrenia treatment (Q26852047) (← links)
- Peripheral biomarkers revisited: integrative profiling of peripheral samples for psychiatric research (Q27012892) (← links)
- Global quantitative analysis of phosphorylation underlying phencyclidine signaling and sensorimotor gating in the prefrontal cortex (Q27319445) (← links)
- Treatment-resistant schizophrenia: current insights on the pharmacogenomics of antipsychotics (Q28079065) (← links)
- Drug models of schizophrenia (Q28084198) (← links)
- Meta-analysis of the efficacy of adjunctive NMDA receptor modulators in chronic schizophrenia (Q28248687) (← links)
- Minocycline benefits negative symptoms in early schizophrenia: a randomised double-blind placebo-controlled clinical trial in patients on standard treatment (Q28265163) (← links)
- The neuregulin-1 receptor erbB4 controls glutamatergic synapse maturation and plasticity. (Q28568657) (← links)
- Disrupted-in-Schizophrenia 1 (DISC1) regulates spines of the glutamate synapse via Rac1 (Q28583457) (← links)
- Impaired prefrontal synaptic gain in people with psychosis and their relatives during the mismatch negativity. (Q30384905) (← links)
- Cannabidiol attenuates sensorimotor gating disruption and molecular changes induced by chronic antagonism of NMDA receptors in mice (Q30403787) (← links)
- Pregnenolone sulfate normalizes schizophrenia-like behaviors in dopamine transporter knockout mice through the AKT/GSK3β pathway (Q30416840) (← links)
- Is the acute NMDA receptor hypofunction a valid model of schizophrenia? (Q30459655) (← links)
- Group II mGluR agonist LY354740 and NAAG peptidase inhibitor effects on prepulse inhibition in PCP and D-amphetamine models of schizophrenia. (Q30466262) (← links)
- A critical role for NMDA receptors in parvalbumin interneurons for gamma rhythm induction and behavior. (Q30468321) (← links)
- NMDA receptor phosphorylation at a site affected in schizophrenia controls synaptic and behavioral plasticity. (Q30484119) (← links)
- Phencyclidine and dizocilpine induced behaviors reduced by N-acetylaspartylglutamate peptidase inhibition via metabotropic glutamate receptors (Q30491856) (← links)
- Using large clinical data sets to infer pathogenicity for rare copy number variants in autism cohorts (Q30572502) (← links)
- Neuroimaging studies in schizophrenia: an overview of research from Asia (Q30573043) (← links)
- Imaging glutamate in schizophrenia: review of findings and implications for drug discovery (Q30685335) (← links)
- Relationship between Glutamate Dysfunction and Symptoms and Cognitive Function in Psychosis (Q30712278) (← links)
- Glutamate-mediated excitotoxicity in schizophrenia: a review (Q30845062) (← links)
- Imaging-based neurochemistry in schizophrenia: a systematic review and implications for dysfunctional long-term potentiation (Q30854782) (← links)
- Inhibition of NMDARs in the Nucleus Reticularis of the Thalamus Produces Delta Frequency Bursting (Q33575236) (← links)
- A Neurophysiological Perspective on a Preventive Treatment against Schizophrenia Using Transcranial Electric Stimulation of the Corticothalamic Pathway (Q33607904) (← links)
- Influence of the NR3A subunit on NMDA receptor functions. (Q33906149) (← links)
- Proton magnetic resonance spectroscopy in 22q11 deletion syndrome (Q33955280) (← links)
- Reviewing the ketamine model for schizophrenia (Q34046060) (← links)
- Relationship between brain glutamate levels and clinical outcome in individuals at ultra high risk of psychosis (Q34270086) (← links)
- GluN2B protein deficits in the left, but not the right, hippocampus in schizophrenia (Q34332929) (← links)
- NR2C in the thalamic reticular nucleus; effects of the NR2C knockout (Q34359217) (← links)
- GABA and glutamate in schizophrenia: a 7 T ¹H-MRS study (Q34446463) (← links)
- Transient Blockade of ERK Phosphorylation in the Critical Period Causes Autistic Phenotypes as an Adult in Mice (Q35627627) (← links)
- Glutamate Networks Implicate Cognitive Impairments in Schizophrenia: Genome-Wide Association Studies of 52 Cognitive Phenotypes (Q35739000) (← links)
- Rare mutations in N-methyl-D-aspartate glutamate receptors in autism spectrum disorders and schizophrenia. (Q35844049) (← links)
- Neuregulin 1 Controls Glutamate Uptake by Up-regulating Excitatory Amino Acid Carrier 1 (EAAC1) (Q35953115) (← links)
- Role of N-Methyl-D-Aspartate Receptors in Action-Based Predictive Coding Deficits in Schizophrenia (Q36137795) (← links)
- Neuroimmune-endocrine crosstalk in schizophrenia and mood disorders (Q36532151) (← links)
- Impaired GABAergic neurotransmission in schizophrenia underlies impairments in cortical gamma band oscillations (Q36678412) (← links)
- The vulnerability to alcohol and substance abuse in individuals diagnosed with schizophrenia (Q36696097) (← links)
- Region-specific changes in gamma and beta2 rhythms in NMDA receptor dysfunction models of schizophrenia (Q36842940) (← links)
- Postsynaptic density levels of the NMDA receptor NR1 subunit and PSD-95 protein in prefrontal cortex from people with schizophrenia (Q36848319) (← links)
- Biomarker investigations related to pathophysiological pathways in schizophrenia and psychosis. (Q36955877) (← links)
- Glutamate and dopamine in schizophrenia: an update for the 21st century (Q36992322) (← links)
- The immunological basis of glutamatergic disturbance in schizophrenia: towards an integrated view. (Q36993204) (← links)